Oklo Inc. requests that their press release NewsItemId: 20250625873788 “Oklo Enters Strategic Collaborations With Hexium and TerraPower to Launch New Pathway for Domestic HALEU Enrichment” be killed.
The three new single-stock ETFs offer daily leveraged and inverse exposure to leading quantum computing, nuclear technology and conversational AI players
The head-turning Wall Street analyst Dan Ives has launched his AI Revolution ETF. Take a deep dive into what his intriguing new fund can offer investors.
Oklo Inc (NYSE:OKLO) shares are trading higher Tuesday after the company announced subsidiary Atomic Alchemy commenced site characterization work at a potential location for a commercial radioisotope production facility.
Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced today that its subsidiary Atomic Alchemy Inc. (“Atomic Alchemy”) has commenced site characterization work at a potential location for a commercial radioisotope production facility in Idaho, at the Idaho National Laboratory (INL).
Oklo Inc (NASDAQ: OKLO) shares are experiencing a volatile trading session on Monday, rocketing to a new all-time high of $73.55 before pulling back. The stock's impressive climb follows a series of significant announcements last week, positioning the company for future growth.
Top mid-cap stocks gain, led by energy companies due to increased oil prices from Middle East conflict. Oklo, Bausch Health, Quantum Computing among top performers.
Oklo Inc. (“Oklo” or the “Company”) (NYSE: OKLO), an advanced nuclear technology company, today announced the pricing of its previously announced underwritten public offering of 6,666,667 shares of its Class A common stock, $0.0001 par value (“common stock”), by the Company at a price to the public of $60.00 per share. In connection with the offering, the Company also granted the underwriters a 30-day option to purchase up to an additional 1,000,000 shares of common stock at the public offering price from the Company. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $400 million, excluding any exercise of the underwriters’ option to purchase additional shares.
